Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Eddie Lampert, Starboard Value LP, Elliott Management, Hartford Financial Services Group (HIG), The Medicines Company (MDCO), and More

Insider Buying At Hartford, Weight Watchers, Selling At Boeing, Salesforce (Forbes)
Back in 1810, a group of businessmen in Hartford, Connecticut formed a fire insurance company for their mutual protection. Today Hartford Financial Services Group (HIG) is one of the largest insurance companies in the U.S. It sells property and casualty insurance, group life and health insurance, and mutual funds. I suspect that many people wouldn’t invest in Hartford because they think of it as old and stodgy. Don’t tell that to Christopher Swift, the CEO. He bought $499,530 of his company’s stock in January. With his wife and affiliated trusts, he controls 208,188 shares, worth just over $10 million as of Friday.

Insider Weekends: Founder Of Entercom Communications Starts Buying Again (SeekingAlpha)
Insider buying decreased significantly last week with insiders purchasing $158.33 million of stock compared to $314.42 million in the week prior. Selling on the other hand increased with insiders selling $3.8 billion of stock last week compared to $2.09 billion in the week prior. A large part of this increase in selling was on account of selling by insiders of Americold Realty Trust (NYSE:COLD) to the tune of $1.29 billion in a secondary offering.

Insider Buys Of The Week: Arconic, CenturyLink, Hain Celestial and More (Benzinga)
Conventional wisdom says insiders and 10 percent owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly during periods of uncertainty. Here’s a look at a few notable insider purchases reported in the past week. Arconic: Pursuant to a Rule 10b5-1 trading plan, chief executive and board chair, John Plant, scooped up a total of 105,000 Arconic Inc ARNC 2.03% shares last week.

In the Lull Between Earnings Seasons, Keep an Eye on Insider Selling (Real Money)
Even though the December-quarter earnings season is only really winding down now, we have just over three weeks until the current quarter comes to an end. Soon after, the March-quarter earnings season begins. Generally speaking, such lulls see investors triangulating what was learned over the last several weeks with the latest information and other cues to prepare for what’s likely ahead. As we’ve talked about in recent Roundups, a growing concern is U.S.-China trade talks may not live up to the expectations being set by the White House.

Select Bancorp Inc (NASDAQ:SLCT) Insider Trading Activity – COO Sold 14,380 Shares of Stock (MarketExclusive)
Insider Trading Activity For Select Bancorp Inc (NASDAQ:SLCT): Lynn H Johnson , COO of Select Bancorp Inc (NASDAQ:SLCT) reportedly Sold 14,380 shares of the company’s stock at an average price of 11.59 for a total transaction amount of $166,664.20.

Monday 3/11 Insider Buying Report: MDCO, STBA (
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. On Wednesday, Medicines (MDCO)’s Director, Alexander J. Denner, made a $6.18M purchase of MDCO, buying 248,100 shares at a cost of $24.91 a piece. So far Denner is in the green, up about 3.0% on their purchase based on today’s trading high of $25.65. Medicines is trading up about 0.3% on the day Monday. Before this latest buy, Denner bought MDCO at 4 other times during the past year, for a total cost of $32.84M at an average of $22.40 per share.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.